International Cancer Research Conference
March 24-26, 2025 | Singapore
Bacteria and Cancer
Bacteria are single-celled organisms that are extremely small. Although the majority of bacteria are harmless, some can infect people and cause diseases. A few have even been linked to the development of cancer. Apart from inducing cancer by interfering with the host's normal defense mechanisms such as inflammation and antigen recognition, some bacteria have been found to produce tumor proteins as a result of metabolic products, which have direct myogenic or mutagenic effects.
Despite the fact that traditional cancer treatments remain the most prominent, bacterial therapy has demonstrated significant results due to its high specificity, ability to control after ingestion, and presence in several live experiments. Because of its tumor selectivity and large gene packaging capability, bacteria targeting tumors is an ideal strategy to administer therapeutic treatments.
- Bacteria Cancer Therapy (BCT)
- Tumor Proteins
- Stomach Cancer and Role of Bacteria
- Engineered Bacterial Strains
- Cancers Associated with Bacterial Infections
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Jianhua Luo
University of Pittsburgh, United States
Patricia Tai
UpToDate, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Getachew Dagne
University of South Florida, United States
Tiantian Zhang
University of Central Florida, United StatesSubmit your abstract Today
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates